 Psychedelicfocused biotech company Mind Medicine Inc. NASDAQ: MNMD NEO: MMED DE: MMQ disclosed on Tuesday that it has agreed to partner with Sphere Health to collect and analyze multimodal data in order to improve the understanding of a variety of biomarkers associated with certain mental illnesses. Under the strategic research collaboration, Sphere Health - a physician-founded employee benefits provider targeting treatments for people with severe mental illness and MindMed are launching MM061302 in an attempt to develop more accurate machine learning tools to identify biomarkers that show association with and prediction of symptoms of anxiety and affective disorders. 